TY - CHAP M1 - Book, Section TI - Pancreatic Hormones and Antidiabetic Drugs A1 - Jobst, Erin E. A1 - Panus, Peter C. A1 - Kruidering-Hall, Marieke PY - 2020 T2 - Pharmacology for the Physical Therapist, 2e AB - CASE STUDYS.L. is a 50-year-old woman with a body mass index of 30 kg/m2 and a 4-year history of type 2 diabetes. Her only medication is metformin, which she takes twice per day. She is a lawyer with a sedentary lifestyle. She admits that she also struggles to adequately monitor her diet. Her recent fingerstick blood glucose levels have ranged from 95 to 280 mg/dL, with the higher values taken after meals. At her recent medical checkup, her A1C was 8.7%, elevated from her previous measurement at 7.5%. Because current metformin monotherapy has failed to control her hyperglycemia, the physician discussed the risks of chronic hyperglycemia as well as options for achieving glycemic control. Following this discussion, S.L. expressed a renewed interest in making a stronger attempt at lifestyle management. The physician encouraged this new commitment. She recommended an outpatient rehabilitation clinic for development of an appropriate exercise program as well as consultation with a dietitican for dietary control. She also prescribed another antidiabetic agent, repaglinide, to decrease postprandial blood glucose elevations. For the past month, S.L. has been participating in an aerobic and resistance exercise program 5 times per week, as initially prescribed by a physical therapist. Today, she arrived at the clinic for a reevaluation and advancement of her exercise program. After assessment of baseline vital signs, the physical therapist started S.L. on the treadmill for an aerobic warm-up. Within 10 minutes, S.L. became diaphoretic and shaky. The therapist assisted her off the treadmill and into a chair. S.L. performed a fingerstick blood glucose reading, which was 53 mg/dL. The therapist brought her some fruit juice and hard candy. Within 30 minutes, S.L. felt well and a second fingerstick blood glucose reading was 92 mg/dL. SN - PB - McGraw-Hill Education CY - New York, NY Y2 - 2023/03/29 UR - accessphysiotherapy.mhmedical.com/content.aspx?aid=1192817395 ER -